Cargando...
CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
BACKGROUND: Patients diagnosed with triple negative breast cancer (TNBC) have limited treatment options and often suffer from resistance and toxicity due to chemotherapy. We previously found that depleting calcium and integrin-binding protein 1 (CIB1) induces cell death selectively in TNBC cells, wh...
Gardado en:
| Publicado en: | Cancer Cell Int |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6360800/ https://ncbi.nlm.nih.gov/pubmed/30740034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0740-2 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|